Immunogenicity of SARS‐CoV‐2 BNT162b2 vaccine in solid organ transplant recipients-Reference-Cited by-同舟云学术

Immunogenicity of SARS‐CoV‐2 BNT162b2 vaccine in solid organ transplant recipients

Published:2021-05-07 Issue:8 Volume:21 Page:2913-2915
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Marinaki Smaragdi¹^ORCID,Adamopoulos Stamatis²,Degiannis Dimitrios³,Roussos Sotirios⁴,Pavlopoulou Ioanna D.⁵,Hatzakis Angelos⁶,Boletis Ioannis N.¹

Affiliation:

1. Clinic of Nephrology and Renal Transplantation NKUA Medical SchoolLaiko General Hospital Athens Greece

2. Heart Failure and Transplant Units Onassis Cardiac Surgery Center Athens Greece

3. Molecular Immunopathology and Histocompatibility Unit Onassis Cardiac Surgery Center Athens Greece

4. Department of Hygiene, Epidemiology and Medical Statistics NKUA Medical School Athens Greece

5. Pediatric Research Laboratory Faculty of Nursing NKUASchool of Health Sciences Athens Greece

6. Hellenic Scientific Society for the Study of AIDS Sexually Transmitted and Emerging Diseases Athens Greece

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.16607

Reference5 articles.

1. Factors associated with COVID-19-related death using OpenSAFELY

2. Influenza Vaccination in the Organ Transplant Recipient: Review and Summary Recommendations†

3. Anti‐Spike protein assays to determine post vaccination antibody levels: a head to head comparison of five quantitative assays;Perkmann T;MedRxiv,2021

4. Immunogenicity of a single dose of SARS‐CoV‐2 messenger RNA vaccine in solid organ transplant recipients;Boyarsky BJ;JAMA,2021

5. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients;Viruses;2024-01-12

2. Weaker SARS-CoV-2 vaccine responses in nonalcoholic fatty liver disease with advanced liver fibrosis;Vaccine: X;2023-12

3. Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of Protection;Vaccines;2023-10-26

4. Low switched memory B cells are associated with no humoral response after SARS-CoV-2 vaccine boosters in kidney transplant recipients;Frontiers in Immunology;2023-10-24

5. Hybrid Immunity Provides the Best COVID-19 Humoral Response in Immunocompromised Patients with or without SARS-CoV-2 Infection History;Vaccines;2023-08-18